Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
| Revenue: | ||||
| Total revenue | $ 421,792 | $ 511,803 | $ 771,049 | $ 1,252,403 |
| Costs and expenses: | ||||
| Cost of products and services | 377,541 | 256,599 | 610,851 | 615,227 |
| Research and development | 296,146 | 280,446 | 568,169 | 716,092 |
| Selling and marketing | 156,892 | 154,014 | 287,065 | 380,029 |
| General and administrative | 1,519,753 | 902,265 | 2,718,062 | 4,260,321 |
| Total operating costs | 2,350,332 | 1,593,324 | 4,184,147 | 5,971,669 |
| Operating loss | (1,928,540) | (1,081,521) | (3,413,098) | (4,719,266) |
| Other (expense) income: | ||||
| Interest Income | 512 | 512 | ||
| Interest expense, net | (3,534,692) | (5,879,653) | (8,919,683) | (9,773,339) |
| Unrealized gain (loss) on investment in equity securities | (583) | 12,184 | 1,899 | 20,245 |
| Gain (loss) on extinguishment of liabilities | (1,622,489) | 28,314 | (2,834,000) | 687,591 |
| Other income (expense) | (30,689) | (2,027) | (26,534) | 4,232 |
| Total other expense | (5,187,941) | (5,841,182) | (11,777,806) | (9,061,271) |
| Net loss | (7,116,481) | (6,922,703) | (15,190,904) | (13,780,537) |
| Deemed dividends on extension of warrants | (3,626,950) | (3,626,950) | ||
| Preferred stock dividends | (632,053) | (565,272) | (1,264,106) | (997,079) |
| Net loss attributable to common shareholders | $ (7,748,534) | $ (11,114,925) | $ (16,455,010) | $ (18,404,566) |
| Basic net loss per share attributable to common shareholders | $ (0.15) | $ (0.57) | $ (0.36) | $ (1.04) |
| Diluted net loss per share attributable to common shareholders | $ (0.15) | $ (0.57) | $ (0.36) | $ (1.04) |
| Weighted average common shares outstanding used in the basic net loss per share calculation | 51,411,779 | 19,471,057 | 45,585,472 | 17,629,225 |
| Weighted average common shares outstanding used in the diluted net loss per share calculation | 51,411,779 | 19,471,057 | 45,585,472 | 17,629,225 |
| Products Services Other [Member] | ||||
| Revenue: | ||||
| Total revenue | $ 421,792 | $ 511,803 | $ 771,049 | $ 1,252,403 |
| X | ||||||||||
- Definition Deemed dividends on extension of warrants. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment in debt and equity securities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as other. No definition available.
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|